PREVIOUS
✖
Lecanemab drug for Alzheimer
January 15 , 2023
1019 days
728
0
- The US Food and Drug Administration has approved lecanemab (Leqembi) for treatment of Alzheimer’s disease.
- Lecanemab, which will be sold under the brand name Leqembi, is the first Alzheimer’s treatment of its kind.
Leave a Reply
Your Comment is awaiting moderation.